Viroclinics-DDL, a vaccine and antiviral specialty laboratory providing research and clinical trial solutions rooted in virology, has changed its name to Cerba Research as of April 1, 2024.   Viroclinics-DDL, with its three specialty laboratory and office locations in the Netherlands, and an extensive partner laboratory network worldwide, has been part of the Cerba Research group since early 2022. By fully entering into the Cerba Research brand now, the company underscores its collective focus...